Slingshot members are tracking this event:
FDA Accepts Supplemental New Drug Application (sNDA) for TEFLARO (ceftaroline fosamil)
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
|AGN||Community voting in process|
Slingshot Insights Explained
Feb 16, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Teflaro, Ceftaroline Fosamil, Skin Structure Infections, Acute Bacterial Skin Infection, Staphylococcus Pneumoniae